Article Data

  • Views 356
  • Dowloads 134

Case Reports

Open Access

Borderline ovarian tumour after fertility sparing surgery for ovarian cancer

  • G.M. Makris1,*,
  • I. Maltezou1
  • C. Chrelias1
  • G. D. Vlachos2
  • N. Papantoniou1

1Gynecological Oncology Unit, Third Department of Obstetrics and Gynecology, General University Hospital “Attikon”, University of Athens, Athens

2First Department of Obstetrics and Gynecology, General University Hospital “Alexandra”, University of Athens, Athens (Greece)

DOI: 10.12892/ejgo3934.2018 Vol.39,Issue 5,October 2018 pp.825-827

Published: 10 October 2018

*Corresponding Author(s): G.M. Makris E-mail:


Borderline ovarian tumours are an intermediate entity between benign and malignant epithelial ovarian neoplasms. The authors present the case of a 25-year-old patient, with a history of fertility-preserving right salpingo-oophorectomy due to an ovarian serous papillary cystadenocarcinoma six years ago. The patient recently presented with a cyst in the left ovary which raised concerns for recurrent disease. The patient underwent a left ovarian cystectomy and the histopathological examination concluded in serous borderline tumour. The patient is followed up regularly, so that a possible relapse will be diagnosed in time. In conclusion, a borderline lesion in the remaining ovary, after ovarian conservative surgery, is a challenge that could represent either a de novo emergence of borderline tumour or possibly the onset of a new ovarian cancer. The study of early molecular alterations could be a promising tool in the investigation of prognosis and management of these lesions.


Borderline ovarian tumour; Recurrent ovarian disease; Fertility sparing; Ovarian cystectomy.

Cite and Share

G.M. Makris,I. Maltezou,C. Chrelias,G. D. Vlachos, N. Papantoniou. Borderline ovarian tumour after fertility sparing surgery for ovarian cancer. European Journal of Gynaecological Oncology. 2018. 39(5);825-827.


[1] Fischerova D., Zikan M., Dundr P., Cibula D.: “Diagnosis, treatment, and follow-up of borderline ovarian tumors”. Oncologist, 2012, 17, 1515.

[2] Seong S.J., Kim da H., Kim M.K., Song T.: “Controversies in borderline ovarian tumors”. J. Gynecol. Oncol., 2015, 26, 343.

[3] Cadron I., Leunen K., Van Gorp T., Amant F., Neven P., Vergote I.: “Management of borderline ovarian neoplasms”. J. Clin. Oncol., 2007, 25, 2928.

[4] Fader A.N., Rose P.G.: “Role of surgery in ovarian carcinoma”. J. Clin. Oncol., 2007, 25, 2873.

[5] Schorge J.O., Eisenhauer E.E., Chi D.S.: “Current surgical management of ovarian cancer”. Hematol. Oncol. Clin. North Am., 2012, 26, 93.

[6] Schlaerth A.C., Chi D.S., Poynor E.A., Barakat R.R., Brown C.L.: “Long-term survival after fertility-sparing surgery for epithelial ovarian cancer”. Int. J. Gynecol. Cancer, 2009, 19, 1199.

[7] Schilder J.M., Thompson A.M., DePriest P.D., Ueland F.R., Cibull M.L., Kryscio R.J., et al.: “Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy”. Gynecol. Oncol., 2002, 87, 1.

[8] Wright J.D., Shah M., Mathew L., Burke W.M., Culhane J., Goldman N., et al.: “Fertility preservation in young women with epithelial ovarian cancer”. Cancer, 2009, 115, 4118.

[9] Zapardiel I., Diestro M.D., Aletti G.: “Conservative treatment of early stage ovarian cancer: oncological and fertility outcomes”. Eur. J. Surg. Oncol., 2014, 40, 387.

[10] Bentivegna E., Morice P., Uzan C., Gouy S.: “Fertility-sparing surgery in epithelial ovarian cancer”. Future Oncol., 2016, 12, 389.

[11] Palomba S., Zupi E., Russo T., Falbo A., Del Negro S., Manguso F., et al.: “Comparison of two fertility-sparing approaches for bilateral borderline ovarian tumours: a randomized controlled study”. Hum. Reprod., 2007, 22, 578.

[12] Vasconcelos I., de Sousa Mendes M.: “Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk:. Eur. J. Cancer, 2015, 51, 620.

[13] Letourneau J., Chan J., Salem W., Chan S.W., Shah M., Ebbel E., et al.: “Fertility sparing surgery for localized ovarian cancers maintains an ability to conceive, but is associated with diminished reproductive potential”. J. Surg. Oncol., 2015, 112, 26.

[14] Kajiyama H., Mizuno M., Shibata K., Yamamoto E., Kawai M., Nagasaka T., Kikkawa F.: “Recurrence-predicting prognostic factors for patients with early-stage epithelial ovarian cancer undergoing fertility-sparing surgery: a multi-institutional study”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2014, 175, 97.

[15] du Bois A., Heitz F., Harter P.: “Fertility-sparing surgery in ovarian cancer: a systematic review”. Onkologie, 2013, 36, 436.

[16] Ditto A., Martinelli F., Lorusso D., Haeusler E., Carcangiu M., Raspagliesi F.: “Fertility sparing surgery in early stage epithelial ovarian cancer”. J. Gynecol. Oncol., 2014, 25, 320.

[17] Kajiyama H., Mizuno M., Shibata K., Umezu T., Suzuki S., Yamamoto E., et al.: “Oncologic outcome after recurrence in patients with stage I epithelial ovarian cancer: are clear-cell and mucinous histological types a different entities?” Eur. J. Obstet. Gynecol. Reprod. Biol., 2014, 181, 305.

[18] Della Pepa C., Tonini G., Santini D., Losito S., Pisano C., Di Napoli M., et al.: “Low grade serous ovarian carcinoma: from the molecular characterization to the best therapeutic strategy”. Cancer Treat. Rev., 2015, 41, 136.

[19] Ditto A., Martinelli F., Bogani G., Lorusso D., Carcangiu M., Chiappa V., et al.: “Long-term safety of fertility sparing surgery in early stage ovarian cancer: comparison to standard radical surgical procedures”. Gynecol. Oncol., 2015, 138, 78.

[20] Fruscio R., Corso S., Ceppi L., Garavaglia D., Garbi A., Floriani I., et al.: “Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series”. Ann. Oncol., 2013, 24, 138.

[21] Girolimetti G., Perrone A.M., Santini D., Barbieri E., Guerra F., Ferrari S., et al.: “BRCA-associated ovarian cancer: from molecular genetics to risk management”. Biomed. Res. Int., 2014, 2014, 787143.

[22] Sun C., Li N., Ding D., Weng D., Meng L., Chen G., Ma D.: “The role of BRCA status on the prognosis of patients with epithelial ovarian cancer: a systematic review of the literature with a meta-analysis”. PLoS One, 2014, 9, e95285.

[23] Bolton K.L., Chenevix-Trench G., Goh C., Sadetzki S., Ramus S.J., Karlan B.Y., et al.: “Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer”. JAMA, 2012, 307, 382.

[24] Kurman R.J., Shih Ie M.: “The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory”. Am. J. Surg. Pathol., 2010, 34, 433.

[25] Nezhat F.R., Apostol R., Nezhat C., Pejovic T.: “New insights in the pathophysiology of ovarian cancer and implications for screening and prevention”. Am. J. Obstet. Gynecol., 2015, 213, 262.

[26] Tsang Y.T., Deavers M.T., Sun C.C., Kwan S.Y., Kuo E., Malpica A., et al.: “KRAS (but not BRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma”. J. Pathol., 2013, 231, 449.

[27] Tinelli R., Tinelli A., Tinelli F.G., Cicinelli E., Malvasi A.: “Conservative surgery for borderline ovarian tumors: a review”. Gynecol. Oncol., 2006, 100, 185.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time